D. McCann

发表

An absence of changes in σ receptor subtypes in the brains of genetically dystonic (dt) rats

T. Su, A. Weissman, D. McCann, 1993 .

Solubilization and characterization of haloperidol-sensitive (+)-[3H]SKF-10,047 binding sites (sigma sites) from rat liver membranes.

T. Su, D. McCann, 1991, The Journal of pharmacology and experimental therapeutics.

Drugs of abuse: management of intoxication and antidotes.

D. McCann, I. Montoya, 2010, EXS.

Sigma‐1 and Sigma‐2 sites in rat brain: Comparison of regional, ontogenetic, and subcellular patterns

T. Su, A. Weissman, D. McCann, 1994, Synapse.

Haloperidol-sensitive (+)[3H]SKF-10,047 binding sites (sigma sites) exhibit a unique distribution in rat brain subcellular fractions.

T. Su, D. McCann, 1990, European journal of pharmacology.

Effects of phencyclidine, N-allyl-N-normetazocine (SKF-10,047), and verapamil on performance in a radial maze

J. C. Winter, D. McCann, 1986, Pharmacology Biochemistry and Behavior.

Use of the radial maze in studies of phencyclidine and other drugs of abuse

J. C. Winter, R. Rabin, D. McCann, 1987, Physiology & Behavior.

Interactions of clonidine with phencyclidine and ketamine: Studies of radial maze performance and righting reflex in rats

J. C. Winter, R. Rabin, D. McCann, 1987, Pharmacology Biochemistry and Behavior.

Phencyclidine/SKF-10,047 binding sites: Evaluation of function

J. C. Winter, R. Rabin, D. McCann, 1989, Pharmacology Biochemistry and Behavior.

Haloperidol competitively inhibits the binding of (+)-[3H]SKF-10,047 to σ sites

T. Su, D. McCann, 1990 .

Measures of outcome for stimulant trials: ACTTION recommendations and research agenda.

Brian D. Kiluk, M. Detke, R. Dworkin, 2016, Drug and alcohol dependence.

A Novel, Nonbinary Evaluation of Success and Failure Reveals Bupropion Efficacy Versus Methamphetamine Dependence: Reanalysis of a Multisite Trial

Shou-Hua Li, D. McCann, 2012, CNS neuroscience & therapeutics.

Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence.

P. Loupe, H. Hallak, O. Cohen‐Barak, 2016, Drug and alcohol dependence.

Outcome Measures in Medication Trials for Substance Use Disorders

P. Skolnick, D. McCann, Tatiana Ramey, 2015, Current Treatment Options in Psychiatry.

Comparison of the effects of methamphetamine, bupropion, and methylphenidate on the self-administration of methamphetamine by rhesus monkeys.

L. Panlilio, S. Goldberg, C. Schindler, 2011, Experimental and clinical psychopharmacology.

Medication Nonadherence, “Professional Subjects,” and Apparent Placebo Responders: Overlapping Challenges for Medications Development

N. Petry, Anders Bresell, D. McCann, 2015, Journal of clinical psychopharmacology.

Trends in opioid analgesic abuse and mortality in the United States.

P. Skolnick, D. McCann, Robert B Bolash, 2015, The New England journal of medicine.

Mitigating the Effects of Nonadherence in Clinical Trials

Earle E. Bain, P. Skolnick, T. Shiovitz, 2016, Journal of clinical pharmacology.

Deception by Research Participants.

D. Resnik, D. McCann, 2015, The New England journal of medicine.

Drug Discovery and Development for Reward Disorders: Views from Government

F. Vocci, J. Acri, D. McCann, 2008 .

Comparison of the Pharmacokinetic Properties of Naloxone Following the Use of FDA‐Approved Intranasal and Intramuscular Devices Versus a Common Improvised Nasal Naloxone Device

C. N. Chiang, D. McCann, P. Krieter, 2019, Journal of clinical pharmacology.

A caution against use of verapamil in phencyclidine intoxication.

D. McCann, J. Winter, C. Smith, 1986, The American journal of psychiatry.

Linear-rank testing of a non-binary, responder-analysis, efficacy score to evaluate pharmacotherapies for substance use disorders

Shou-Hua Li, T. Holmes, D. McCann, 2018, Statistical methods in medical research.